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Finally, we agree that OPCAB does
not require occlusion of coronary arteries
during each anastomosis but disagree that
the routine insertion of a shunt is the stan-
dard by which most cardiac centers prac-
tice OPCAB. There are concerns about the
risk of coronary injury with the insertion of
a shunt,3 particularly in the population of pa-
tients referred for coronary artery bypass
grafting with poor-quality targets. Because
this injury might also provoke regional in-
flammation and thrombosis, we have used
shunts selectively for those with evidence
of ischemia after brief coronary occlusion.
Admittedly, this is an area that requires
further analysis.
Robert Poston, MD
Department of Surgery
University of Maryland School of Medicine
Baltimore, Md
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Letters to the EditorMinimally invasive implantation
of a cardioverter in children
To the Editor:
We read with interest the case report of
Snyder and coworkers1 regarding the im-
plantation of a cardioverter in a 3-year-old
child with a minimally invasive approach.
In this case the authors used a dual-coil
shocking lead looped around the heart and
fixed on the epicardium. The sensing elec-
trode was set on the right ventricle, and the
implantable cardioverter–defibrillator was
secured in the left abdominal wall.
We fully agree with the authors that de-
fibrillators should be considered more often
in the pediatric population and that an epi-
cardial approach is the only acceptable route
in this population.2 However, we have some
concerns with their proposed approach. The
looping coil might lead to progressive com-
pression of epicardial vessels (coronary
veins and even arteries) with the patient’s
growth and might further get dislodged or
even break with growth. Breakage is prone
to occur when the coil is readily fixed at dif-
ferent points (here by adhesions and sutur-
ing on the heart), and the risk is greater in
a dual coil than in a simple one. Finally, de-
vices set in the lower abdominal wall result
in a large gap between electrodes, coils, and
device with growth (much larger than when
set in the thoracic cavity) and can induce
abdominal complications.3
We have also developed an epicardial
technique for this population in which the
heart is set between the coil and the defi-
brillator, which acts as an active pole.4The Journal of Thoracic and CardiovasculThe coil is positioned under the parietal
pleura at the apex of the left thorax, and
the defibrillator is positioned underneath
the heart, within the diaphragm layers
(between the aponeurosis and muscle).
Sensing electrodes are positioned on the
epicardium of the left ventricle (which has
superior sensing parameters compared
with the right ventricle) (Figure 1).5 The
leads are looped in the left pleural cavity.
Growth results in a progressive unlooping
of the leads but without any tension on
the heart and with minimal modification
of the relationship between the coil and
the defibrillator, which basically remain
around the heart. Like the authors, we
avoid a sternotomy. Change of an element
of the defibrillator because of a structural
failure (if any should occur with time)
would not be a problem because of the ab-
sence of significant adhesions on the heart.
We have used this technique in 14 chil-
dren with ages ranging from 2.9 to 13.2
years, with excellent sensing and defibrilla-
tion thresholds (successful defibrillation is
usually achieved with 10 to 15 J). The
Medtronic wireless communication system
allows effective remote telemetry of the
device (something not possible with any
telemetric system). We have not seen any
structural failure caused by somatic growth.
Rene´ Preˆtre, MD
Urs Bauersfeld, MD
Department of Surgery
University Children’s Hospital
Zurich, SwitzerlandFigure 1. Frontal and lateral chest radiographs of
a 6-year-old boy with subpleural placement of the
defibrillator electrode and intra-diaphragmatic
position of the device.ar Surgery c Volume 136, Number 1 239
who responded to medical treatment (2.4 6
0.6 mm) and those who did not respond to
medical management (2.8 6 0.9 mm) was
extremely low (116% or 0.4 mm). Even if
an average difference of 0.4 mm appears to
be significant (P 5 .006) in statistical
terms, we question how such a small differ-
ence can be clinically significant. This is
particularly relevant because the difference
in PDA size observed in the 2 groups
largely overlaps with the reproducibility er-
ror for repeated measurements of similar
cardiac structures by means of echocardi-
ography.
Concerning the proposed 9 mm2/kg cut-
off value, direct visual assessment of the fig-
ure provided suggests that no clear cutoff
exists to discern patients who can be man-
agedmedically and thosewhowill ultimately
require surgical intervention. Accordingly,
19 (49%) of 39 reported patients with
a PDA of larger than 9 mm2/kg actually re-
sponded to medical treatment alone and
Reply to the Editor:
In their letter Drs Giardini and Derrick
summarize the statistical analysis and the
findings of our article pertaining to the ef-
fect of ductal diameter in preterm babies
as diagnosed by means of echocardio-
graphic analysis and its relevance to the
choice of therapy and success rate for pat-
ent ductus arteriosus (PDA) closure. They
conclude that the current data do not indi-
cate a clear cutoff value as to selecting pa-
tients for primary surgical PDA closure. I
agree with their statement and am relieved
that they read the article so carefully be-
cause no such pretence is stated anywhere
in the text.
First, in the conclusions of the abstract, it
is stated that medical treatment is a valid first
option, but it is likely to fail with larger PDA
diameters and lower birth dates. Further-
more, ‘‘hospital stay might be shortened
by earlier surgical referral . index greater
than 9 mm2/kg.’’
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surgical and medical closure of
patent ductus arteriosus in
preterm neonates
To the Editor:
We read with interest the article by Tschup-
pert and colleagues1 on the effect of ductal
diameter on surgical and medical closure
of patent ductus arteriosus (PDA) in preterm
neonates. The question that the study aims
to answer is quite relevant. Indeed, PDA is
a common and potentially lethal condition
in preterm neonates and is associated with
significant comorbidities and resource
use.2 Tschuppert and colleagues1 suggest
that PDA size can be used to predict patients
in whom medical management is likely to
fail to achieve hemodynamic irrelevance.
In particular, they suggest that patients
with PDA areas of greater than 9 mm2/kg
should be offered primary surgical closure
at the time of diagnosis.
We think some comments are worth re-
porting on the study.
It is known that there is an inverse asso-
ciation between PDA size and the rate of
closure after indomethacin administration
in premature infants.3 As a consequence,
a difference in PDA size between patients
who do and those who do not respond to
indomethacin would be expected. A sur-
prising result of the present study is that
the difference in PDA diameter in patients
would have been erroneously sent to surgical
intervention by using the proposed cutoff
value. Also, 27 (17%) of the 162 patients
with a PDA of smaller than 9 mm2/kg would
be erroneously considered medically man-
ageable, thus requiring delayed PDA surgi-
cal closure and longer intensive care unit
stay.
Overall, we think the present study indi-
cates that no clear cutoff exists to select
patients who should undergo primary surgi-
cal PDA closure.
Alessandro Giardini, MD
Graham Derrick, MD
Cardiothoracic Unit
Great Ormond Street Hospital for Children
London, United Kingdom
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In the conclusions of the Discussion sec-
tion, it is repeated that medical treatment is
the valid initial therapy in the absence of
contraindications to medication and hemo-
dynamic instability. ‘‘Patients with an index
of greater than 9 mm2/kg would probably
benefit from early direct surgical closure at
the end of any given medical protocol..’’
Statistical analysis of data, nomatter how
robust or clear-cut, which is not the case in
the present study and is clearly acknowl-
edged as such, cannot replace common sense
and good clinical judgment. We have not in-
troduced a new magical number by which
a binary decision process should be made,
thereby replacing medical treatment for
PDA closure in preterm babies. Rather an in-
dex is presented, which can serve as a guide-
line to clinicians dealing with these patients
to avoid undue delay in proposing and
undertaking surgical PDA ligation.1
Ali Dodge-Khatami, MD, PhD
Division of Congenital Heart Surgery
University Children’s Hospital
Zurich, Switzerland
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